Startups
Founded in 2012 and located in Minneapolis, Minnesota, Imbio turns medical images into life changing insights, with emphasis on machine learning and AI, we are making exceptional personalized medicine attainable. For more information, please visit imbio.com
- Our Lung Density Analysis is FDA Cleared and CE Mark Certified
- Validated on 1,000s of prior patients
- COPD is the 4th leading cause of death worldwide
- Achieved fully automated efficiency results that are delivered to you in minutes
- Offer proprietary diagnostics from the most trusted named in healthcare
- Our Lung Density Analysis is FDA Cleared and CE Mark Certified
- Validated on 1,000s of prior patients
- COPD is the 4th leading cause of death worldwide
- Achieved fully automated efficiency results that are delivered to you in minutes
- Offer proprietary diagnostics from the most trusted named in healthcare
Overview
Location
United States, Minnesota, Minneapolis
Employees
11-50
Founded date
2012
Founders name
Troy Kopischke
Founders Related Locations
United States, Michigan, Sault Ste. Marie; United States, Minnesota, Minneapolis
Persons 1
| Date | First Name | Last Name | Title | |||
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 4, 2025 | 4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology | Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- 4DMedical, a leader in advanced respiratory imaging, today announces... |
| Sep 27, 2021 | Imbio Partners with MEDICAL-NOTE to Expand Image Analysis Tool Offering to Clinicians across Italy | Imbio, a medical imaging artificial intelligence (AI) provider for chronic lung and cardiothoracic diseases, and MEDICAL-NOTE, an applications and software company for surgical procedure management and multi-disciplinary team communication,... |
| Mar 18, 2015 | U-M Spinout Imbio Uses Big Data to Improve COPD Diagnostics | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Cynthia Maier, CEO of the University of Michigan spinout startup Imbio, is fond of saying her company bridges the gap between bench and bedside when it comes to biomarker imag... |
Reviews 0
FAQ about Imbio
When was Imbio founded?
Imbio was founded in 2012.
What has the press written about Imbio?
Parsers VC has collected 4 articles mentioning Imbio, among them “4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology” (Sep 4, 2025) and “Imbio Partners with MEDICAL-NOTE to Expand Image Analysis Tool Offering to Clinicians across Italy” (Sep 27, 2021).
Is Imbio still active?
Yes, Imbio is active; its latest activity on Parsers VC dates from Jun 29, 2026.